Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| Instrumentālo mainīgo (IV) metode cēloņsakarību noteikšanai× | Lēmumu analītiskā modelēšana veselības ekonomikā× | |
|---|---|---|
| Nozare | Veselības ekonomika | Veselības ekonomika |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 1990s (modern applications) | 1975 |
| Autors≠ | Angrist & Pischke (applied econometrics); rooted in econometric theory | Pauker & Kassirer (medical decision analysis, Massachusetts General Hospital) |
| Tips | Method | Method |
| Pirmavots≠ | Angrist, J. D., & Pischke, J. S. (2009). Mostly Harmless Econometrics: An Empiricist's Companion. Princeton: Princeton University Press. link ↗ | Pauker, S. G., & Kassirer, J. P. (1975). Therapeutic Decision Making: A Cost-Benefit Analysis. New England Journal of Medicine, 293(5), 229-234. DOI ↗ |
| Citi nosaukumi | IV, two-stage least squares, TSLS, causal estimation | decision analysis, decision tree, decision model, health economic model |
| Saistītās≠ | 3 | 5 |
| Kopsavilkums≠ | Instrumental variables (IV) is an econometric method to estimate causal effects when treatment or exposure is not randomly assigned and confounding is severe or unmeasured. IV relies on a third variable (instrument) that influences treatment but does not directly affect the outcome, allowing researchers to isolate the causal effect from the noise of confounding. Developed extensively in econometrics (Angrist & Pischke, 1990s–2000s), IV methods are increasingly used in health economics and health services research to leverage natural experiments and policy changes. | Decision analytic modeling is a systematic framework for comparing health interventions by integrating evidence on probabilities, outcomes, costs, and patient preferences into a quantitative model. Developed by Pauker and Kassirer in 1975, decision analysis structures clinical uncertainty and economic trade-offs, enabling transparent comparison of treatment options and identification of optimal strategies. Used in health technology assessment, clinical practice guideline development, and resource allocation decisions. |
| ScholarGateDatu kopa ↗ |
|
|